Yuzhi Wang Selected Research

Yuzhi Wang Research Topics

Disease

20	Neoplasms (Cancer) 05/2024 - 02/2015
9	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2014
8	Carcinogenesis 02/2024 - 10/2015
5	Chronic Renal Insufficiency 08/2023 - 10/2021
4	Inflammation (Inflammations) 04/2023 - 01/2022
3	Acute Kidney Injury (Acute Renal Failure) 04/2023 - 01/2022
2	Adenocarcinoma of Lung 01/2023 - 01/2023
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 10/2015
1	Hemorrhage 05/2024
1	Port-Wine Stain (Nevus Flammeus) 04/2024
1	Vascular System Injuries 04/2024
1	Obesity 02/2024
1	COVID-19 01/2024
1	Melanosis (Freckles) 01/2024
1	Wound Infection (Wound Infections) 12/2023
1	Margins of Excision 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Squamous Cell Carcinoma of Head and Neck 06/2023
1	Iron Overload 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2022
1	Stomach Neoplasms (Stomach Cancer) 02/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Non-alcoholic Fatty Liver Disease 10/2021
1	Melanoma (Melanoma, Malignant) 01/2021

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 01/2022
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2023
3	Long Noncoding RNAIBA 08/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 02/2022 - 10/2020
3	CarcinogensIBA 01/2022 - 10/2015
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024 - 01/2021
2	UbiquitinIBA 02/2024 - 01/2018
2	Untranslated RNA (Noncoding RNA)IBA 11/2023 - 01/2018
2	6-methyladenineIBA 11/2023 - 06/2023
2	SmokeIBA 05/2022 - 01/2022
2	Perindopril FDA LinkGeneric 01/2022 - 10/2021
2	Estrogen ReceptorsIBA 01/2019 - 01/2018
2	GATA Transcription FactorsIBA 12/2018 - 01/2018
2	Phenobarbital (Luminal)FDA Link 01/2018 - 09/2014
1	hematoporphyrin monomethyl etherIBA 04/2024
1	Ligases (Synthetase)IBA 02/2024
1	Mevalonic Acid (Mevalonate)IBA 02/2024
1	Hydroxymethylglutaryl-CoA SynthaseIBA 02/2024
1	CholesterolIBA 02/2024
1	SterolsIBA 02/2024
1	Melanins (Melanin)IBA 01/2024
1	Fibroblast Growth Factor 10IBA 12/2023
1	Local Anti-Infective Agents (Antiseptics)IBA 12/2023
1	Ointments (Pastes)IBA 12/2023
1	Small Nuclear RNA (snRNA)IBA 11/2023
1	RNA Polymerase II (RNA Polymerase B)IBA 11/2023
1	honokiolIBA 08/2023
1	Messenger RNA (mRNA)IBA 06/2023
1	IronIBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	CatalaseIBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	AcetyltransferasesIBA 01/2023
1	Orlistat (Xenical)FDA Link 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	InterleukinsIBA 01/2023
1	San-HuangIBA 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2023
1	pristane (pristan)IBA 01/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 02/2022
1	Nicotine FDA Link 01/2022
1	NitrosaminesIBA 01/2022
1	PhytochemicalsIBA 01/2022
1	Huang QiIBA 01/2022
1	4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	7,8-dihydromethysticinIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	KetonesIBA 01/2022
1	jianpi yishenIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Adenine FDA LinkGeneric 01/2022
1	DNA AdductsIBA 01/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022
1	sarkosylIBA 12/2021
1	EpitopesIBA 12/2021
1	AntioxidantsIBA 10/2021
1	Sirtuin 3IBA 10/2021
1	LipidsIBA 10/2021
1	porphyceneIBA 01/2021

Therapy/Procedure

7	Therapeutics 05/2024 - 02/2015
4	Immunotherapy 01/2023 - 01/2015
2	Nephrectomy 05/2024 - 11/2023
2	Drug Therapy (Chemotherapy) 04/2023 - 01/2022
1	Lasers (Laser) 04/2024
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Chemoprevention 01/2022